BMEA (STOCKS)
Biomea Fusion, Inc. Common Stock
$1.880000
+0.010000 (+0.53%)
Prev close: $1.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Michael J. M. Hitchcock
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $135.56M
- Employees
- 63
- P/E (TTM)
- -1.23
- P/B (TTM)
- 4.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.86M |
| Benefits Costs and Expenses | $63.66M |
| Costs And Expenses | $63.66M |
| Operating Expenses | $83.51M |
| Research and Development | $61.98M |
| Other Operating Expenses | $21.53M |
| Operating Income/Loss | -$83.51M |
| Income/Loss From Continuing Operations After Tax | -$61.80M |
| Income/Loss From Continuing Operations Before Tax | -$61.80M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Income/Expense After Provision For Losses | $1.86M |
| Interest Income/Expense Operating, Net | $1.86M |
| Net Income/Loss | -$61.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$61.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$61.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.18 |
| Diluted Earnings Per Share | -$1.18 |
| Basic Average Shares | 52,228,068 |
| Diluted Average Shares | 52,228,068 |
| Assets | $58.57M |
| Current Assets | $58.05M |
| Noncurrent Assets | $522.00K |
| Fixed Assets | $153.00K |
| Other Non-current Assets | $369.00K |
| Liabilities | $29.02M |
| Current Liabilities | $11.10M |
| Accounts Payable | $3.23M |
| Wages | $2.96M |
| Other Current Liabilities | $4.91M |
| Noncurrent Liabilities | $17.92M |
| Equity | $29.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.55M |
| Liabilities And Equity | $58.57M |
| Net Cash Flow From Operating Activities | -$70.37M |
| Net Cash Flow From Operating Activities, Continuing | -$70.37M |
| Net Cash Flow From Investing Activities | $2.47M |
| Net Cash Flow From Investing Activities, Continuing | $2.47M |
| Net Cash Flow From Financing Activities | $67.90M |
| Net Cash Flow From Financing Activities, Continuing | $67.90M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$61.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$61.80M |
| Other Comprehensive Income/Loss | $0.00 |